Publications by authors named "Alexander Reinthaller"

Claim this Profile
P
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer.
Paul Gass, Falk C Thiel, Lothar Häberle, Sven Ackermann, Anna-Katharin Theuser, Alexander Reinthaller

Gynecol Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful one-stage resection of intracardiac intravenous leiomyomatosis: A case report.
Postl Magdalena, Bartl Thomas, Poetsch Nina, Reinthaller Alexander, Andreas Martin

Gynecol Oncol Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer.
Irina Tsibulak, Stephan Polterauer, Alexander Reinthaller, Christian Schauer, Jürg Berger

Wien Klin Wochenschr· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients.
Christina T Grech, Dietmar Pils, Stefanie Aust, Christoph Grimm, Stephan Polterauer, Alexander Reinthaller

J Pers Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial.
Stephan Polterauer, Olaf Reich, Andreas Widschwendter, Laudia Hadjari, Gerhard Bogner, Alexander Reinthaller

Gynecol Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pretreatment Controlling Nutritional Status Score in Ovarian Cancer: Influence on Prognosis, Surgical Outcome, and Postoperative Complication Rate.
Christine Bekos, Christoph Grimm, Lisa Gensthaler, Thomas Bartl, Alexander Reinthaller

Geburtshilfe Frauenheilkd· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.
Philipp Harter, Jalid Sehouli, Ignace Vergote, Gwenael Ferron, Alexander Reuss, Alexander Reinthaller

N Engl J Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial.
Keiichi Fujiwara, Hiroyuki Fujiwara, Hiroyuki Yoshida, Toyomi Satoh, Kan Yonemori, Alexander Reinthaller

J Gynecol Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer-A Study of the OVCAD Consortium.
Eva Obermayr, Angelika Reiner, Burkhard Brandt, Elena Ioana Braicu, Alexander Reinthaller

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 and PD-L1 expression on TILs in peritoneal metastases compared to ovarian tumor tissues and its associations with clinical outcome.
Christine Bekos, Dietmar Pils, Sabine Dekan, Gerda Hofstetter, Peter Horak, Alexander Reinthaller

Sci Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients.
Thomas Bartl, Jasmine Karacs, Caroline Kreuzinger, Stephanie Pfaffinger, Jonatan Kendler, Alexander Reinthaller

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of frailty on the management of patients with gynecological cancer aged 80 years and older.
Elisabeth Reiser, Nina Pötsch, Veronika Seebacher, Alexander Reinthaller, Friedrich Wimazal

Arch Gynecol Obstet· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer.
Thomas Bartl, Christine Bekos, Magdalena Postl, Reinthaller Alexander, Stephan Polterauer

J Gynecol Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data.
Felicitas Oberndorfer, Sarah Moling, Leonie Annika Hagelkruys, Christoph Grimm, Stephan Polterauer, Alexander Reinthaller

J Pers Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patients.
Konstantina Panoutsopoulou, Margaritis Avgeris, Paraskevi Magkou, Konstantinos Mavridis, Tobias Dreyer, Alexander Reinthaller

Int J Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective.
Irina Tsibulak, Elisabeth Reiser, Gerhard Bogner, Edgar Petru, Johanna Hell-Teutsch, Alexander Reinthaller

Int J Gynecol Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real-World Precision Cancer Medicine Platform.
Hossein Taghizadeh, Robert M Mader, Leonhard Müllauer, Stefanie Aust, Stephan Polterauer, Alexander Reinthaller

Oncologist· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study.
Konstantina Panoutsopoulou, Margaritis Avgeris, Konstantinos Mavridis, Tobias Dreyer, Julia Dorn, Alexander Reinthaller

Carcinogenesis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low anterior resection syndrome (LARS) in ovarian cancer patients - A multi-centre comparative cohort study.
Felix Harpain, Marlene Kranawetter, Tobias Zott, Ioannis I Lazaridis, Marc-Olivier Guenin, Alexander Reinthaller

Int J Surg· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Jacobus Pfisterer, Catherine M Shannon, Klaus Baumann, Joern Rau, Philipp Harter, Alexander Reinthaller

Lancet Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Viewing Disney Movies During Chemotherapy on Self-Reported Quality of Life Among Patients With Gynecologic Cancer: A Randomized Clinical Trial.
Sophie Pils, Johannes Ott, Alexander Reinthaller, Enikoe Steiner, Stephanie Springer

JAMA Netw Open· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Medicine Tumor Boards: Clinical Applicability of Personalized Treatment Concepts in Ovarian Cancer.
Stefanie Aust, Richard Schwameis, Tamara Gagic, Leonhard Müllauer, Eva Langthaler, Alexander Reinthaller

Cancers (Basel)· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Isabelle Ray-Coquard, Patricia Pautier, Sandro Pignata, David Pérol, Antonio González-Martín, Alexander Reinthaller

N Engl J Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7).
Alexander Reuss, Andreas du Bois, Philipp Harter, Christina Fotopoulou, Jalid Sehouli, Alexander Reinthaller

Int J Gynecol Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-operative hypoalbuminemia is associated with complication rate and overall survival in patients with vulvar cancer undergoing surgery.
Christine Bekos, Stephan Polterauer, Veronika Seebacher, Thomas Bartl, Elmar Joura, Alexander Reinthaller

Arch Gynecol Obstet· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis